Stock & Company Details
Cns Pharmaceuticals Inc $CNSP
Price:
N/A
N/A
1.5M
$7.5M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.18
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CNSP technical indicators
Latest Cns Pharmaceuticals Inc (CNSP) indicator readings as of 2026-09-18.
CNSP's 14-day RSI is 39.3, in neutral territory. At $5.11 it is trading 6.9% above its 200-day moving average of $4.78, and below its 50-day average of $5.47. Price sits below the lower Bollinger Band ($5.19 to $6.20). ADX reads 17.5, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Finance Bot
Ask your questions
Start by typing a question below.
